DYN FY 2010 Earnings — Dyne Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

DYNDyne Therapeutics, Inc.

$3B

FY 2010 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2.3B-5.9% YoY

Gross Profit

$1.1B49.2% margin

Operating Income

-$11M-0.5% margin

Net Income

-$234M-10.1% margin

EPS (Diluted)

$-1.93

Cash Flow

Operating Cash Flow

$423M

Free Cash Flow

$90M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$10.0B

Total Liabilities

$7.3B

Stockholders' Equity

$2.7B

Cash & Equivalents

$291M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.3B	$2.5B	-5.9%
Gross Profit	$1.1B	$1.3B	-10.4%
Operating Income	-$11M	-$834M	+98.7%
Net Income	-$234M	-$1.3B	+81.5%